Showing results (201-210 of 446) with videos related to
Sort By:
Pageof 45
Health Policy (Amsterdam, Netherlands)|September 21, 2024
Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysisJames Larkin, Britta Matthes, Mohamed Azribi, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2021
Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational studyAngelyn Anton, Shirley Wong, Julia Shapiro, et al.Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.Asia-Pacific Journal of Clinical Oncology|September 24, 2020
Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive diseaseAndrew Schmidt, Angelyn Anton, Julia Shapiro, et al.Journal of Clinical Epidemiology|February 23, 2025
Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch studyJames Larkin, Uchechukwu Alanza, Vikneswaran Raj Nagarajan, et al.EJNMMI Research|June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PETLaura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.Clinical and Experimental Dermatology|April 17, 2025
Grade 3 and Grade 4 Cutaneous toxicities in patients across multiple solid tumour types receiving checkpoint inhibitor therapy: An observational study. The experience of a single large specialist institutionZaina Sharif, James Larkin, Lisa Pickering, et al.British Journal of Cancer|October 21, 2015
The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanomaAnna Wilkins, Andrew Furness, Richard W Corbett, et al.Pageof 45